Giulia De Napoli

Giulia De Napoli

Auto-generated profile, based on publicly available information

Giulia De Napoli

Department of Biomedical, Metabolic and Neurosciences, University of Modena and Reggio Emilia, Modena, Italy

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 December 2025 in Multiple Sclerosis Journal
Verified
Journal Article
Closed access
GNGiulia De Napoli
Giulia De Napoli
EGEnrico Gotti
Enrico Gotti
CBChiara Baldovini
Chiara Baldovini
LSLuisa Di Sciascio
Luisa Di Sciascio
FVFrancesca Vitetta
Francesca Vitetta
DFDiana Ferraro
Diana Ferraro
A 42-year-old man with relapsing-remitting multiple sclerosis and no prior cardiac history developed a severe but reversible left ventricular systolic dysfunction following ocrelizumab administration. Symptoms started 24–36 hours after the infusion and worsened over 10 days. A thorough diagnostic evaluation, including blood tests, coronary artery angiography, cardiac magnetic resonance imaging, and endomyocardial biopsy excluded ischemic or infectious causes of myocardial damage. Although cardiac complications have not previously been reported with ocrelizumab, this case suggests the drug may rarely cause reversible severe cardiac dysfunction and highlights the importance of vigilance for cardiotoxicity in people with multiple sclerosis.